anti-Early Growth Response 3 (EGR3) Antibodies

Human Early Growth Response 3 (EGR3) interaction partners

1. KSRP (show KHSRP Antibodies) decreased EGR3 mRNA stability in an ARE-independent manner.

2. miR (show MLXIP Antibodies)-718 acts as a tumor suppressive microRNA in hepatocellular carcinoma via regulating the expression of EGR3, which may provide a new diagnostic marker and treatment target for HCC (show FAM126A Antibodies)

3. Egr2 (show EGR2 Antibodies) and Egr3 have emerged as regulatory molecules that suppress excessive immune responses. Mice deficient for Egr2 (show EGR2 Antibodies) and Egr3 develop a lupus-like disease with dysregulated activation of effector T cells. Egr2 (show EGR2 Antibodies) and Egr3 confer suppressive activity to CD4 (show CD4 Antibodies)(+) T cells and regulate the production of inhibitory cytokines such as IL-10 (show IL10 Antibodies) and TGF-beta1 (show TGFB1 Antibodies).

4. EGR3 contributes to cell growth inhibition via upregulation of FasL (show FASL Antibodies) in Hepatocellular carcinoma.

5. In the PPI network, genes may be involved in Down syndrome (DS) by interacting with others, including nuclear receptor subfamily 4 group A member 2 (NR4A2 (show NR4A2 Antibodies))early growth response (EGR)2 (show EGR2 Antibodies) and NR4A2EGR3. Therefore, RUNX1 (show RUNX1 Antibodies), NR4A2 (show NR4A2 Antibodies), EGR2 (show EGR2 Antibodies), EGR3 and ID4 (show ID4 Antibodies) may be key genes associated with the pathogenesis of DS.

6. These findings support previously reported associations between EGR3 and schizophrenia.

7. EGR3 promotes excessive production of IL6 (show IL6 Antibodies) and IL8 (show IL8 Antibodies) observed during the progression of prostate cancer.

8. Data shows association of Egr3 genetic polymorphisms and coronary artery disease in the Uygur and Han of China

9. Genetic variation in EGR3 may affect prefrontal function through neurodevelopment

10. These results provide the first evidence that Egr-3, is up-regulated in scleroderma and is necessary and sufficient for profibrotic responses.

Mouse (Murine) Early Growth Response 3 (EGR3) interaction partners

1. Egr2 (show EGR2 Antibodies) and Egr3 expressed in T cells cooperatively prevent humoral immune responses by supporting TGF-beta3 (show TGFB3 Antibodies) secretion.

2. Study demonstrates in mice that explored novel spatial environments, the involvement of Egr3 in regulating the late protein-dependent phase of Arc (show NOL3 Antibodies) expression in the dentate gyrus.

3. Egr2 (show EGR2 Antibodies) and 3 are upstream regulators of effector CD4 (show CD4 Antibodies) and CD8 (show CD8A Antibodies) T cells that are essential for optimal responses with limited immunopathology.

4. Egr2 and 3 are antagonists of T-bet function in effector T cells and are important for the control of inflammatory responses of T cells.

5. Egr3 knockout mice, lacking muscle spindles, but not Golgi tendon organs, displayed a less severe prepubertal scoliosis.

6. Egr3 is involved in myoblast proliferation by interaction with survival signaling.

7. Study showed that acute stress activates 5-HT2AR expression in the mouse cortex and this activation requires the immediate early (show JUN Antibodies) gene Egr3

8. demonstrate a novel function of EGR2 (show EGR2 Antibodies)/3 that is important for Tfh cell development and Tfh cell-mediated B cell immune responses

9. Gene expression profiling and further functional validation revealed that Egr3 was a strong limiting factor for the proliferative potential of hematopoietic stem cells in leukemia.

10. Egr3 overexpression in medium spiny neurons subtypes oppositely mediates behavioral responses to cocaine. Egr3 regulates cocaine-associated genes transcriptionally

Medaka Early Growth Response 3 (EGR3) interaction partners

1. Expression of both the egr1 (show EGR1 Antibodies) and egr3 mRNAs were observed in the telencephalon, hypothalamus, and optic tectum, however, the positions at which the genes were expressed were different.